カテゴリ： MarketLine, 企業調査, 日本

Shionogi & Co., Ltd.：企業の戦略・SWOT・財務分析

◆英語タイトル：Shionogi & Co., Ltd. - Strategy, SWOT and Corporate Finance Report
◆商品コード：SWOT20MY4333
◆発行会社（調査会社）：MarketLine
◆発行日：2020年2月
◆ページ数：50
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：日本
◆産業分野：Pharmaceuticals and Healthcare
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Shionogi & Co., Ltd. – Strategy, SWOT and Corporate Finance Report
Summary

Shionogi & Co., Ltd. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Shionogi & Co., Ltd. (Shionogi or ‘the group’) is engaged in the research, development, manufacture, and marketing of ethical drugs, over-the-counter (OTC) drugs and diagnostic products. The company offers its products under its brands: Crestor, Irbetan, AIMIX, IRTRA, Cymbalta, Pirespa, Differin, Rapiacta, Finibax, OxyContin, OxiNorm, OxiFast, Sedes, Correct Series, opon Series, Brightpoc Flu, Allerport TARC and HISCL-TARC. It operates in Japan, Europe, North America and other regions of the world. The company is headquartered in Osaka, Japan.

Scope

- Detailed information on Shionogi & Co., Ltd. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Shionogi & Co., Ltd. in the form of a SWOT analysis
- An in-depth view of the business model of Shionogi & Co., Ltd. including a breakdown and examination of key business segments
- Intelligence on Shionogi & Co., Ltd.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Shionogi & Co., Ltd., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Shionogi & Co., Ltd. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Shionogi & Co., Ltd. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Shionogi & Co., Ltd.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Shionogi & Co., Ltd.: Company Overview
Shionogi & Co., Ltd.: Overview and Key Facts
Shionogi & Co., Ltd.: Overview
Shionogi & Co., Ltd.: Key Facts
Shionogi & Co., Ltd.: Key Employees
Shionogi & Co., Ltd.: Key Employee Biographies
Shionogi & Co., Ltd.: Major Products and Services
Shionogi & Co., Ltd.: Company History
Shionogi & Co., Ltd.: Management Statement
Shionogi & Co., Ltd.: Locations and Subsidiaries
Shionogi & Co., Ltd.: Key Competitors
Shionogi & Co., Ltd.: Company Analysis
Shionogi & Co., Ltd.: Business Description
Shionogi & Co., Ltd.: SWOT Analysis
Shionogi & Co., Ltd.: SWOT Overview
Shionogi & Co., Ltd.: Strengths
Shionogi & Co., Ltd.: Weaknesses
Shionogi & Co., Ltd.: Opportunities
Shionogi & Co., Ltd.: Threats
Shionogi & Co., Ltd.: Corporate Financial Deals Activity
Shionogi & Co., Ltd.: Financial Deals Overview
Shionogi & Co., Ltd.: Targets and Partners
Shionogi & Co., Ltd.: Top Deals 2016 – 2020YTD*
Shionogi & Co., Ltd.: Mergers and Acquisitions
Shionogi & Co., Ltd.: Corporate Venturing
Shionogi & Co., Ltd.: Partnership
Shionogi & Co., Ltd.: Divestments
Shionogi & Co., Ltd.: Recent Developments
Shionogi & Co., Ltd.: News and Events Summary
Shionogi & Co., Ltd.: Business Expansion
Shionogi & Co., Ltd.: Business Reorganization
Shionogi & Co., Ltd.: Contracts
Shionogi & Co., Ltd.: Corporate Governance
Shionogi & Co., Ltd.: Financial Performance
Shionogi & Co., Ltd.: Regulatory and Legal Events
Shionogi & Co., Ltd.: Research & Development
Shionogi & Co., Ltd.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Shionogi & Co., Ltd.: Key Facts
Table 2: Shionogi & Co., Ltd.: Key Employees
Table 3: Shionogi & Co., Ltd.: Company History
Table 4: Shionogi & Co., Ltd.: Locations and Subsidiaries
Table 5: Shionogi & Co., Ltd.: Key Competitors
Table 6: Shionogi & Co., Ltd.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Shionogi & Co., Ltd.: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 8: Shionogi & Co., Ltd.: Targets and Partners
Table 9: Shionogi & Co., Ltd.: Top Deals 2016 - 2020YTD*
Table 10: Shionogi & Co., Ltd.: M&A Volume and Value Trend (2016 - YTD*2020)
Table 11: Shionogi & Co., Ltd.: Corporate Venturing Volume and Value Trend (2016 - YTD*2020)
Table 12: Shionogi & Co., Ltd.: Corporate Venturing by Geography (2016 - YTD*2020)
Table 13: Shionogi & Co., Ltd.: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 14: Shionogi & Co., Ltd.: Partnership Trend by Deal Type (2016 - YTD*2020)
Table 15: Shionogi & Co., Ltd.: Divestments Volume and Value Trend (2016 - YTD*2020)
Table 16: Shionogi & Co., Ltd.: News and Events Summary
Table 17: Shionogi & Co., Ltd.: Business Expansion
Table 18: Shionogi & Co., Ltd.: Business Reorganization
Table 19: Shionogi & Co., Ltd.: Contracts
Table 20: Shionogi & Co., Ltd.: Corporate Governance
Table 21: Shionogi & Co., Ltd.: Financial Performance
Table 22: Shionogi & Co., Ltd.: Regulatory and Legal Events
Table 23: Shionogi & Co., Ltd.: Research & Development
Table 24: Shionogi & Co., Ltd.: Strategy and Operations

★海外企業調査レポート[Shionogi & Co., Ltd.：企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Eneva SA (ENEV3)：石油・ガス：M&Aディール及び事業提携情報
    Summary Eneva SA (Eneva), formerly MPX Energia SA, is an integrated energy company. The company offers power generation, energy commercialization, and exploration and production of hydrocarbons and natural gas. Its power generation portfolio includes fossil fuels such as coal and natural gas, and re …
  • Apex Healthcare Berhad (AHEALTH)：企業の財務・戦略的SWOT分析
    Apex Healthcare Berhad (AHEALTH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Target Corp：企業の戦略・SWOT・財務情報
    Target Corp - Strategy, SWOT and Corporate Finance Report Summary Target Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Verastem Inc (VSTM)：製薬・医療：M&Aディール及び事業提携情報
    Summary Verastem Inc (Verastem) is a clinical-stage biopharmaceutical company with focus on the discovery, development and commercialization of drugs to treat cancer. The company’s lead product candidates include duvelisib, defactinib (VS-6063), FAK inhibitor (VS-4718) and PI3K/mTOR inhibitor (VS-55 …
  • Hitachi Ltd (6501)：企業の財務・戦略的SWOT分析
    Hitachi Ltd (6501) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Daisy Group PLC：企業のM&A・事業提携・投資動向
    Daisy Group PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Daisy Group PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • SCSK Corporation：企業の戦略・SWOT・財務分析
    SCSK Corporation - Strategy, SWOT and Corporate Finance Report Summary SCSK Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Energy Recovery Inc (ERII)：企業の財務・戦略的SWOT分析
    Energy Recovery Inc (ERII) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Entegris Inc (ENTG)：企業の財務・戦略的SWOT分析
    Summary Entegris Inc (Entegris) is a manufacturer and supplier of micro contamination control products, specialty chemicals, and advanced materials handling solutions. The company offers products for wafer shipping and processing; gas filtration and purification; mask and reticle handling; hard disk …
  • Pfizer Inc (PFE)：企業の財務・戦略的SWOT分析
    Pfizer Inc (PFE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Aditya Birla Retail Ltd：企業の戦略的SWOT分析
    Aditya Birla Retail Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Cancer Research Institute：製薬・医療：M&Aディール及び事業提携情報
    Summary Cancer Research Institute (CRI) is a non-profit cancer research organization that discovers and develops immunotherapy for treating various types of cancer. The organization offers clinical trials for breast cancer, colorectal cancer, lung cancer, melanoma and prostate cancer. Its programs c …
  • Crinetics Pharmaceuticals Inc (CRNX)：製薬・医療：M&Aディール及び事業提携情報
    Summary Crinetics Pharmaceuticals Inc (Crinetics) is a developer of novel therapeutics targeting peptide hormone receptors for the treatment of rare endocrine disorders and endocrine-related cancers. The company’s products include neuropeptides and their receptors, orally-available somatostatin agon …
  • Egton Medical Information Systems Ltd (EMIS)-医療機器分野：企業M&A・提携分析
    Summary Egton Medical Information Systems Ltd (EMIS) is a medical technology company that develops and offers software solutions for the healthcare industry. The company offers software products such as EMIS web, which is used for clinical services; EMIS IQ for data extraction services; symphony tha …
  • Uflex Limited：企業の戦略・SWOT・財務情報
    Uflex Limited - Strategy, SWOT and Corporate Finance Report Summary Uflex Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Exosome Diagnostics Inc：企業の製品パイプライン分析
    Summary Exosome Diagnostics Inc (Exosome Diagnostics) is a provider of diagnostic solutions. The company develops, designs, manufactures and markets biofluid-based molecular diagnostic tests and products for use in personalized medicine. Exosome Diagnostics’ services comprise miRNA profiling, mRNA p …
  • Advance Synergy Berhad：企業の戦略・SWOT・財務情報
    Advance Synergy Berhad - Strategy, SWOT and Corporate Finance Report Summary Advance Synergy Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Marshall of Cambridge (Holdings) Ltd：企業の戦略・SWOT・財務情報
    Marshall of Cambridge (Holdings) Ltd - Strategy, SWOT and Corporate Finance Report Summary Marshall of Cambridge (Holdings) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • JEOL Ltd. (6951)：企業の財務・戦略的SWOT分析
    JEOL Ltd. (6951) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Saracen Mineral Holdings Ltd：企業の戦略・SWOT・財務分析
    Saracen Mineral Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Saracen Mineral Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆